Alkem Lab

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
5,435.50
138.5 (2.61%)
BSENSE

Mar 25

BSE+NSE Vol: 63.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,435.50",
    "chg": 138.5,
    "chgp": "2.61%",
    "dir": 1,
    "prev_price": "5,297.00",
    "mcapval": "63,719.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "63.34 k",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916531",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916531.png",
        "date": "2026-03-25 15:01:03",
        "description": "Alkem Laboratories Ltd has witnessed a significant 18.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a moderate 2.5% gain in the stock price, the underlying volume and open interest dynamics suggest nuanced directional bets amid a cautiously optimistic pharmaceutical sector backdrop."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916392.png",
        "date": "2026-03-25 14:00:48",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock outperformed its sector peers with a 2.87% gain on 25 Mar 2026, supported by a 15.48% rise in open interest and robust volume patterns, reflecting evolving investor positioning ahead of upcoming catalysts."
      },
      {
        "title": "Alkem Laboratories Sees Significant Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amid-bullish-derivatives-activity-3916293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916293.png",
        "date": "2026-03-25 13:00:37",
        "description": "Alkem Laboratories Ltd has witnessed a notable 12.78% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent upgrade to a Sell rating by MarketsMOJO, the stock has outperformed its sector and broader indices over the past two days, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3910795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3910795.png",
        "date": "2026-03-24 15:00:44",
        "description": "Alkem Laboratories Ltd has witnessed a significant 22.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock trades below all major moving averages, reflecting underlying caution amid mixed technical and fundamental cues."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3910667",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3910667.png",
        "date": "2026-03-24 14:00:39",
        "description": "Alkem Laboratories Ltd has witnessed a significant 17.9% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite the stock’s recent outperformance relative to its sector, technical indicators and volume patterns suggest a complex interplay of bullish and cautious sentiment among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3910535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3910535.png",
        "date": "2026-03-24 13:00:28",
        "description": "Alkem Laboratories Ltd has witnessed a notable 14.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock trades below all major moving averages, reflecting a cautious outlook amid mixed volume and delivery trends."
      },
      {
        "title": "Alkem Laboratories Declines 1.75%: Technical Weakness and Flat Financials Weigh",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-175-technical-weakness-and-flat-financials-weigh-3905251",
        "imagepath": "",
        "date": "2026-03-21 14:02:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Mojo Grade downgraded to Sell amid mixed financial and technical signals</p>\n                    <p><strong>16 Mar:</strong> Mildly bearish technical shift confirmed with mixed momentum indicators</p>\n                    <p><strong>19 Mar:</strong> Sharp intraday decline of 2.02% on heavy volume</p>\n                    <p><strong>20 Mar:</strong> Slight recovery with 0.32% gain, week closes at Rs.5,257.75</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,351.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label..."
      },
      {
        "title": "Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3892850",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_mojoScore_3892850.png",
        "date": "2026-03-16 08:11:08",
        "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 March 2026. This revision reflects a combination of deteriorating technical indicators, flat recent financial performance, and concerns over long-term growth prospects despite solid management efficiency and fair valuation metrics."
      },
      {
        "title": "Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-signals-3892759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_technicaldot_3892759.png",
        "date": "2026-03-16 08:02:39",
        "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock exhibits a complex interplay of technical indicators, reflecting both cautious investor sentiment and pockets of resilience."
      }
    ],
    "total": 523,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding 'Intimation of Opening of Trading Window'.",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 01, 2019, titled \"Closure of US FDA Inspection at Alkem s manufacturing facility located at Daman, India and Baddi, India. \".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"Update on US FDA Inspection at Alkem s Bioequivalence Center at Taloja\".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Alkem Laboratories Limited - Updates

13-Nov-2019 | Source : NSE

Alkem Laboratories Limited has informed the Exchange regarding 'Intimation of Opening of Trading Window'.

Alkem Laboratories Limited - Press Release

01-Nov-2019 | Source : NSE

Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 01, 2019, titled "Closure of US FDA Inspection at Alkem s manufacturing facility located at Daman, India and Baddi, India. ".

Alkem Laboratories Limited - Press Release

22-Oct-2019 | Source : NSE

Alkem Laboratories Limited has informed the Exchange regarding a press release dated October 22, 2019, titled "Update on US FDA Inspection at Alkem s Bioequivalence Center at Taloja".

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alkem Laboratories Ltd has declared 2150% dividend, ex-date: 20 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available